Hypertrophic Obstructive Cardiomyopathy

Hypertrophic Obstructive Cardiomyopathy: Volume, Distribution, and Mortality

Hypertrophic Obstructive Cardiomyopathy: Patient Volume

2017 - 2020

Hypertrophic obstructive cardiomyopathy (HOCM) is the thickening of the lower chambers of the heart. The septal muscle, which divides the right and left chambers, is especially affected by HOCM. The condition can impede blood flow from the heart to the aorta. Cleveland Clinic physicians use a comprehensive approach to diagnose and treat patients with HOCM. This includes a physical exam, electrocardiograph, chest X-ray, echocardiogram, and magnetic resonance imaging.

Patient Type2017 Volume2018 Volume2019 Volume2020 Volume
Total HOCM outpatient visits3281371441183390
New patients with HOCM541720781592

HOCM = hypertrophic obstructive cardiomyopathy

Hypertrophic Obstructive Cardiomyopathy: Surgical Volume

2016 - 2020, N = 234

Cleveland Clinic continues to be one of the national leaders in volume and treatment outcomes for patients with hypertrophic obstructive cardiomyopathy (HOCM).

Source: STS Adult Cardiac Surgery Database

In 2020, Cleveland Clinic surgeons performed 234 procedures to treat patients with HOCM.

Hypertrophic Obstructive Cardiomyopathy: Surgical Procedure Distribution

2020, N = 234

Cleveland Clinic surgeons perform isolated and a variety of combination procedures to treat patients with hypertrophic obstructive cardiomyopathy (HOCM).

CABG = coronary artery bypass grafting

Source: STS Adult Cardiac Surgery Database

ᵃProcedural percentages are rounded.

Septal Myectomy: In-Hospital Mortality

2016 – 2020

The in-hospital mortality rates among patients who have septal myectomies at Cleveland Clinic are lower than the expected rates.

Source: Data from the Vizient Clinical Data Base used with permission of Vizient, Inc. All rights reserved.